SCHEMBL7034667

SCHEMBL7034667

[c]1nc2c(-c3ccccc3SCc3ccccc3)cccc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
GSTP1 P09211 1/20 0.34
GSTM2 P28161 1/20 0.34
HSD17B10 Q99714 1/20 0.34
EGFR P00533 5/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MAPT P10636 3/20 0.34
ATM Q13315 1/20 0.34
KMT2A Q03164 3/20 0.33
SAE1 Q9UBE0 2/20 0.33
UBA2 Q9UBT2 2/20 0.33
MEN1 O00255 1/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
S100A4 P26447 1/20 0.33
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7131658 0.77
SCHEMBL38090 0.74 POLB (0.41) POLBGSTP1GSTM2HSD17B10EGFR
SCHEMBL3287916 0.70 TOP2A (0.41) HSD17B10RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL10706324 0.70 NPC1 (0.39) POLBHSD17B10RAB9ASMN1; SMN2NPC1
SCHEMBL9034353 0.69 POLB (0.42) POLBHSD17B10EGFRRAB9ASMN1; SMN2
SCHEMBL6051921 0.69 ALDH1A1 (0.41) HSD17B10RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL6777717 0.67 POLB (0.59) POLBHSD17B10EGFRRAB9ASMN1; SMN2
SCHEMBL10763514 0.66 POLB (0.45) POLBHSD17B10EGFRRAB9ASMN1; SMN2
SCHEMBL558171 0.65 KDM4E (0.41) POLBHSD17B10RAB9ASMN1; SMN2NPC1
SCHEMBL4355515 0.65 POLB (0.44) POLBGSTP1GSTM2HSD17B10EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6777406-B2 SUCH AS PYRIDO(3,2,1-IJ)PYRROLO(3,4-C)QUINOLIN-8-ONE DERI-VATIVES; CENTRAL NERVOUS SYSTEM DISORDERS; GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-17 US disclosed